Citius Pharmaceuticals (CTXR) Files $250M Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CTXR Hot Sheet
Join SI Premium – FREE
Citius Pharmaceuticals (NASDAQ: CTXR) has filed $250,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units and/or
Rights
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Prologis launches $5B at-the-market equity offering program
- Annovis Bio flags NYSE noncompliance over market cap and equity
- Citibank to redeem $2.5 billion in notes due 2026
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
